| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2023 | TMDX Transmedics Group, Inc. | Gordon Stephen52 | Chief Financial Officer | Sell | 5,000 | $54.22 | $271,100.00 | -21.0% | +45.5% | +174.4% | |
| Oct 2, 2023 | SIBN Si-Bone, Inc. | Dunn Jeffrey W70 | Director | Sell | 20,000 | $21.19 | $423,738.00 | -22.3% | -1.7% | -35.7% | |
| Oct 2, 2023 | PEN Penumbra Inc | Sarna Surbhi67 | Director | Sell | 85 | $240.99 | $20,484.15 | -3.4% | +2.6% | -19.7% | |
| Oct 2, 2023 | GKOS Glaukos Corp | Burns Thomas William | Chairman &CEO | Sell | 45,000 | $71.98 | $3,239,262.05 | -11.9% | +8.4% | +78.0% | |
| Oct 2, 2023 | RMD Resmed Inc | Rider Michael J49 | Global General Counsel | Sell | 25 | $145.92 | $3,648.00 | -0.3% | +17.9% | +63.8% | |
| Oct 2, 2023 | SIBN Si-Bone, Inc. | Maheshwari Anshul67 | Chief Financial Officer | Sell | 1,244 | $21.15 | $26,309.85 | -0.8% | -1.7% | -35.7% | |
| Oct 2, 2023 | PEN Penumbra Inc | Roberts Johanna54 | EVP, Gen. Counsel &Secretary | Sell | 600 | $237.82 | $142,690.65 | -0.2% | +2.6% | -19.7% | |
| Oct 2, 2023 | EW Edwards Lifesciences Corp | Mussallem Michael A65 | Director | Sell | 29,350 | $68.84 | $2,020,454.00 | -86.7% | +9.2% | -5.9% | |
| Sep 29, 2023 | EW Edwards Lifesciences Corp | Ullem Scott B.65 | Cvp, Chief Financial Officer | Sell | 7,255 | $69.54 | $504,527.21 | -27.4% | +10.7% | -3.9% | |
| Sep 29, 2023 | PACB Pacific Biosciences Of California, Inc. | Kim Susan G.77 | See Remarks | Sell | 19,257 | $8.44 | $162,471.31 | -5.9% | +24.1% | -79.0% | |
| Sep 28, 2023 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 464 | $14.16 | $6,570.24 | -0.4% | +20.0% | +73.2% | |
| Sep 28, 2023 | UFPT Ufp Technologies Inc | Holt Jason | Vice President | Sell | 400 | $156.57 | $62,628.00 | -6.1% | +11.9% | +104.7% | |
| Sep 28, 2023 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 659 | $14.16 | $9,331.44 | -0.2% | +20.0% | +73.2% | |
| Sep 28, 2023 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality Officer | Sell | 568 | $14.16 | $8,042.88 | -0.5% | +20.0% | +73.2% | |
| Sep 28, 2023 | BLFS Biolife Solutions Inc | Rice Michael72 | Chief Executive Officer | Sell | 831 | $14.16 | $11,766.96 | -0.2% | +20.0% | +73.2% | |
| Sep 27, 2023 | IRMD Iradimed Corp | Susi Roger E.53 | CEO, President, Chairman | Sell | 10,000 | $43.29 | $432,934.53 | -1.7% | +6.4% | +12.6% | |
| Sep 27, 2023 | ATEC Alphatec Holdings, Inc. | Miles Patrick53 | CEO | Sell | 179,375 | $12.66 | $2,270,075.00 | -1.1% | +18.2% | -57.7% | |
| Sep 26, 2023 | NXGL Nexgel, Inc. | Stein John Nachum62 | Director | Buy | 2,500 | $1.96 | $4,900.00 | +0.5% | +15.5% | +34.2% | |
| Sep 26, 2023 | LFWD Lifeward Ltd. | Lind Global Fund II LP51 | - | Buy | 5,031,200 | $0.70 | $3,521,840.00 | +103.5% | +1.1% | -38.1% | |
| Sep 26, 2023 | LFWD Lifeward Ltd. | Lind Global Fund II LP51 | - | Sell | 5,031,200 | $0.70 | $3,521,840.00 | -100% | +1.1% | -38.1% | |
| Sep 26, 2023 | LUCD Lucid Diagnostics Inc. | Lapidus Stanley74 | Director | Sell | 29,947 | $1.45 | $43,459.15 | -6.0% | -5.4% | -48.7% | |
| Sep 25, 2023 | CTKB Cytek Biosciences, Inc. | Jeanmonod Patrik77 | Chief Financial Officer | Sell | 3,000 | $6.38 | $19,140.00 | -2.9% | +47.6% | -19.0% | |
| Sep 25, 2023 | BFLY Butterfly Network, Inc. | Stoica Andrei G53 | Chief Technology Officer | Sell | 3,300 | $1.21 | $3,976.50 | -0.3% | -8.6% | +41.4% | |
| Sep 22, 2023 | DXCM Dexcom Inc | Pacelli Steven Robert57 | EVP Managing Director Dexcom V | Sell | 411 | $88.40 | $36,332.40 | -0.3% | +40.3% | -19.5% | |
| Sep 22, 2023 | LUNG Pulmonx Corp | Rose Geoffrey Beran81 | Chief Commercial Officer | Sell | 1,184 | $10.51 | $12,443.84 | -0.5% | +22.8% | -16.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.